Gland Pharma to invest Rs 400 crore to expand its Telangana plant

The expanded site is envisaged to meet the national and international regulations to be followed in the manufacturing of the biological products as applicable and shall be built under the GMP guidelines applicable for the respective product lines, it said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/JqUtZSF
via IFTTT